Clinical trial
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney…
NCT00491517 · Mario Negri Institute for Pharmacological Research, Other · Completed
Key facts
| NCT number | NCT00491517 |
|---|---|
| Title | Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety |
| Official title | Sirolimus Treatment in Patients With ADPKD |
| Acronym | SIRENA |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Polycystic Kidney |
| Intervention type | Drug |
| Interventions | Sirolimus, conventional therapy |
| Enrollment | 22 |
| Start date | Mar 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jun 26, 2007 |
| Last update posted | Apr 24, 2013 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: